_444812.webp)
About Vivek Pharmachem (India) Limited
Data last updated: 06 March 2026
Vivek Pharmachem (India) Limited is a public limited company based in Jaipur, Rajasthan, India. It specialises in wind energy solutions, a part of the broader environmental services sector. Incorporated on 29 January 1990, the company has been in operation for over 36 years.
Registered with ROC Jaipur under CIN U24232RJ1990PLC005283.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹14.25 Cr. Formerly known as Vivek Pharmaceuticals Private Limited. It is led by directors including Navdeep Gupta and Rishi Bhandari.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 1 Sethi Colony, Jaipur, Rajasthan, India – 302004.
As per the financials filed for FY 2025, the company reported a revenue of ₹245.53 Cr, a decline of 8% compared to the previous year.
The company has a workforce of approximately 51 employees as per the latest available data. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹84.02 Cr and satisfied charges of ₹137.92 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivekpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressA – 1 Sethi Colony, Jaipur, Rajasthan, India – 302004
-
IndustryEnvironment, Wind Energy Solutions, Solar Energy Solutions
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) Limited is engaged in principal business activities including manufacturing and electricity, gas, steam and air condition supply, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, electric power generation, transmission and distribution. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| D | Electricity, gas, steam and air condition supply | D1 | Electric power generation, transmission and distribution | Locked |
Business activity turnover details for Vivek Pharmachem (India) Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) Limited is audited by R Sogani & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R Sogani & Associates | Locked | Locked | Locked |
Complete auditor history for Vivek Pharmachem (India) Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) Limited is currently managed by 6 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Navdeep Gupta
Also directs:
Vivek Pharmaceuticals Private Limited, Vivek Constructions Pvt Ltd., Uppasana Constructions P. Ltd. and 2 more
|
Whole-Time Director | 29 Jan 1990 | 36 Years 5 Months | Current |
|
Rishi Bhandari
Also directs:
Medi Rasayan Private Limited
|
Director | 24 Dec 2024 | 1 Years 7 Months | Current |
|
Rahul Bhandari
Also directs:
Medi Rasayan Private Limited
|
Director | 24 Dec 2024 | 1 Years 7 Months | Current |
|
Ashwin Gupta
Also directs:
Vivek Pharmaceuticals Private Limited, Vivek Constructions Pvt Ltd., Uppasana Constructions P. Ltd. and 3 more
|
Director | 24 Jan 2026 | 0 Years 6 Months | Current |
| Aruna Gupta | Director | 24 Jan 2026 | 0 Years 6 Months | Current |
|
Varun Gupta
Also directs:
Pacific Global Limited, Orchid Medicare Private Limited
|
Director | 24 Jan 2026 | 0 Years 6 Months | Current |
Financials of Vivek Pharmachem (India) Limited FY 2025 filings available
Vivek Pharmachem (India) Limited reported revenue of ₹245.53 Cr (down 8.00% YoY) for FY 2025.
Ten-year financial statements for Vivek Pharmachem (India) Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vivek Pharmachem (India) Limited
Shareholding and ownership data for Vivek Pharmachem (India) Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Vivek Pharmachem (India) Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Vivek Pharmaceuticals Private Limited | U21001RJ2023PTC089149 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Vivek Pharmachem (India) Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2024 | Hdfc Bank Limited | ₹12 Cr | Open |
| 31 Jul 2023 | Others | ₹1.35 Cr | Open |
| 10 Mar 2023 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 05 Feb 2020 | Hdfc Bank Limited | ₹20.18 Cr | Open |
| 03 Mar 2004 | Others | ₹50 Cr | Open |
Total charge records: 24 View all charges
Employees and EPFO Compliance at Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) Limited has a workforce of 51 employees as of Dec 06, 2025.
Employee and EPFO history for Vivek Pharmachem (India) Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Vivek Pharmachem (India) Limited
GST registrations and filing compliance for Vivek Pharmachem (India) Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Vivek Pharmachem (India) Limited
Credit ratings, litigation, and regulatory alerts for Vivek Pharmachem (India) Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vivek Pharmachem (India) Limited
MSME payment history for Vivek Pharmachem (India) Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vivek Pharmachem (India) Limited
Corporate group structure for Vivek Pharmachem (India) Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vivek Pharmachem (India) Limited
MCA filings and documents for Vivek Pharmachem (India) Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Vivek Pharmachem (India) Limited
Frequently Asked Questions about Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) Limited is an active public limited company in the environment sector based in Jaipur, Rajasthan, India. It was incorporated on 29 January 1990 (36+ years old) and is registered under CIN U24232RJ1990PLC005283. The company has 51 employees.
Vivek Pharmachem (India) Limited reported revenue of ₹245.53 Cr for FY 2025 (down 8.00% YoY).
The current directors of Vivek Pharmachem (India) Limited are:
- Navdeep Gupta - Whole-Time Director
- Rishi Bhandari - Director
- Rahul Bhandari - Director
- Ashwin Gupta - Director
- Aruna Gupta - Director
- Varun Gupta - Director
The primary industry of Vivek Pharmachem (India) Limited is environment. The company specifically operates in wind energy solutions. The company is currently active in this sector.
Vivek Pharmachem (India) Limited can be reached at the registered office: A – 1 Sethi Colony, Jaipur, Rajasthan, India – 302004, or through the website vivekpharma.com.
The authorised capital is ₹20 Cr, and the paid-up capital is ₹14.25 Cr.